
Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

